Effectiveness of Using a Chatbot to Promote Adherence to Home Physiotherapy

September 2, 2022 updated by: Jose María Blasco Igual, University of Valencia

Herramienta de Procesamiento de Lenguaje Natural en Dispositivo móvil Inteligente Para Fomentar la Adherencia a la rehabilitación Domiciliaria

A Chatbot oriented to virtually assist patients in a physiotherapy treatment has been designed and developed to interact with patients with musculoskeletal disorders in need for domiciliary rehabilitation. The tool has been designed to promote adherence to rehabilitation, what in turn may have an impact on clinical outcome. A randomized clinical trial involving patients undergoing total knee replacement has bee designed to determine the applicability of the proposal. The participants will be assigned into exerimental group (intervention with the software tool) or control group (standard care).

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Valencia, Spain, 46026

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 75 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Individuals on the waiting list for total knee replacement surgery
  • Undergoing primary total knee replacement surgery
  • Who have a personal smartphone
  • Who have an instant messaging application installed
  • Familiar with the use of such application (more than 3 accesses per week),

Exclusion Criteria:

  • Evident cognitive state that prevents to understand care provider instructions
  • Vestibular or central nervous system affection (e.g. stroke)
  • Cannot read or write
  • Do not understand Spanish language
  • Not able to consent to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Control
The physiotherpy treatment will be standard care
EXPERIMENTAL: Experimental
The physiotherpy treatment will be supervised via chatbot

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: Change from baseline to 3 months after surgery date
Compliance with intervention measured as the percentage of sessions carried out with respect to the total planned
Change from baseline to 3 months after surgery date

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Change from baseline to 3 months and one year after surgery date
Self-administered questionnaire consisting of 24 items divided into pain, stiffness and physical function will register self-reported status. The score is given from 0 to 100
Change from baseline to 3 months and one year after surgery date
Knee Pain
Time Frame: Change from baseline to 3 months and one year after surgery date
Measured with a visual analogue scale of pain, being 0 no pain and 10 the worst possible pain
Change from baseline to 3 months and one year after surgery date

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety
Time Frame: Baseline (surgery day) to 12 months
Adverse events, defined as any unfavorable or unintended diagnosis, sign, symptom, or disease associated with the study
Baseline (surgery day) to 12 months
Feasibility_1
Time Frame: Time from initial day to last day of recruitment up to two years
Recruitment rate, obtained by dividing the number of participants divided by the number patients invited
Time from initial day to last day of recruitment up to two years
Feasibility_2
Time Frame: Time from initial day to 3 months after surgery date
Retention rate, obtained by dividing the number of participants assessed at three months by the total number of participants
Time from initial day to 3 months after surgery date
International Physical Activity Questionnaire (IPAQ-E)
Time Frame: Change from baseline to 3 months after surgery date
This questionnaire is used to measure the types of intensity of physical activity and sitting time as part of the participants' daily lives, i.e. the total physical activity in MET-min/week and time spent sitting
Change from baseline to 3 months after surgery date
System Usability
Time Frame: Change from baseline to 3 months after surgery date
System usability scale will be used for measuring the usability; this consists of a 10 item questionnaire with five response options from Strongly agree to Strongly disagree
Change from baseline to 3 months after surgery date

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2022

Primary Completion (ANTICIPATED)

June 1, 2023

Study Completion (ANTICIPATED)

June 1, 2024

Study Registration Dates

First Submitted

May 2, 2022

First Submitted That Met QC Criteria

May 2, 2022

First Posted (ACTUAL)

May 5, 2022

Study Record Updates

Last Update Posted (ACTUAL)

September 8, 2022

Last Update Submitted That Met QC Criteria

September 2, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • NLP-PTAdherence

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Chatbot Assistant

3
Subscribe